Summit Asset Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-2,788
| Closed | -$208K | – | 156 |
|
2021
Q3 | $208K | Buy |
2,788
+52
| +2% | +$3.88K | 0.07% | 145 |
|
2021
Q2 | $253K | Sell |
2,736
-975
| -26% | -$90.2K | 0.08% | 132 |
|
2021
Q1 | $329K | Buy |
3,711
+492
| +15% | +$43.6K | 0.11% | 107 |
|
2020
Q4 | $300K | Sell |
3,219
-60
| -2% | -$5.59K | 0.11% | 109 |
|
2020
Q3 | $209K | Buy |
+3,279
| New | +$209K | 0.09% | 122 |
|